LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

AIMS: To report preliminary data on baseline serum calcitonin concentrations and associated clinical characteristics in a global population with type 2 diabetes before liraglutide or placebo randomization. METHODS: The ongoing LEADER trial has enrolled 9340 people with type 2 diabetes and at high ri...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetes Obes Metab
Главные авторы: Daniels, G H, Hegedüs, L, Marso, S P, Nauck, M A, Zinman, B, Bergenstal, R M, Mann, J F E, Derving Karsbøl, J, Moses, A C, Buse, J B, Tuttle, R M
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Publishing Ltd 2015
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405040/
https://ncbi.nlm.nih.gov/pubmed/25656058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12444
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы